Pharmacokinetics, Pharmacodynamics and Bioavailability of ACM‐001.1 (<i>S</i>‐Pindolol Benzoate) in Healthy Volunteers
Data from this bridging study of enantiomerically pure ACM-001.1 and its parent racemic drug, pindolol, support clinical trials of ACM-001.1 for the treatment of cancer cachexia.
Authors
- John McDermott (ORCID: https://orcid.org/0000-0002-5220-8837)
- Dennis R. Henderson
- Stefan Wohlfeil
- Frank Misselwitz (ORCID: https://orcid.org/0000-0003-1366-7958)
- Somasekhara R. Menakuru
- Gareth Whitaker
- Chris Roe
- Elaine Morten
Institutions
- Quotient Clinical (United Kingdom) (GB)
Publication Details
- Journal
- Journal of Cachexia Sarcopenia and Muscle
- Published
- 2024-12-12
- DOI
- https://doi.org/10.1002/jcsm.13651
- Citations
- 4
- Primary Topic
- Histone Deacetylase Inhibitors Research
- Type
- article
- Field-Weighted Citation Impact
- 0.94